These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

552 related articles for article (PubMed ID: 11094262)

  • 1. NKT cells: facts, functions and fallacies.
    Godfrey DI; Hammond KJ; Poulton LD; Smyth MJ; Baxter AG
    Immunol Today; 2000 Nov; 21(11):573-83. PubMed ID: 11094262
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Regulation of tumor immunity: the role of NKT cells.
    Ambrosino E; Berzofsky JA; Terabe M
    Expert Opin Biol Ther; 2008 Jun; 8(6):725-34. PubMed ID: 18476784
    [TBL] [Abstract][Full Text] [Related]  

  • 3. alpha-Galactosylceramide therapy for autoimmune diseases: prospects and obstacles.
    Van Kaer L
    Nat Rev Immunol; 2005 Jan; 5(1):31-42. PubMed ID: 15630427
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Control of NKT cell differentiation by tissue-specific microenvironments.
    Yang Y; Ueno A; Bao M; Wang Z; Im JS; Porcelli S; Yoon JW
    J Immunol; 2003 Dec; 171(11):5913-20. PubMed ID: 14634102
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Immunoregulation of autoimmunity by natural killer T cells.
    Linsen L; Somers V; Stinissen P
    Hum Immunol; 2005 Dec; 66(12):1193-202. PubMed ID: 16690406
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Tissue-specific expansion of NKT and CD5+B cells at the onset of autoimmune disease in (NZBxNZW)F1 mice.
    Morshed SR; Mannoor K; Halder RC; Kawamura H; Bannai M; Sekikawa H; Watanabe H; Abo T
    Eur J Immunol; 2002 Sep; 32(9):2551-61. PubMed ID: 12207339
    [TBL] [Abstract][Full Text] [Related]  

  • 7. The regulatory role of Valpha14 NKT cells in innate and acquired immune response.
    Taniguchi M; Harada M; Kojo S; Nakayama T; Wakao H
    Annu Rev Immunol; 2003; 21():483-513. PubMed ID: 12543936
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Natural killer T cells as targets for therapeutic intervention in autoimmune diseases.
    Wilson MT; Van Kaer L
    Curr Pharm Des; 2003; 9(3):201-20. PubMed ID: 12570826
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Human invariant V alpha 24-J alpha Q TCR supports the development of CD1d-dependent NK1.1+ and NK1.1- T cells in transgenic mice.
    Capone M; Cantarella D; Schümann J; Naidenko OV; Garavaglia C; Beermann F; Kronenberg M; Dellabona P; MacDonald HR; Casorati G
    J Immunol; 2003 Mar; 170(5):2390-8. PubMed ID: 12594262
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Surface receptors identify mouse NK1.1+ T cell subsets distinguished by function and T cell receptor type.
    Stenström M; Sköld M; Ericsson A; Beaudoin L; Sidobre S; Kronenberg M; Lehuen A; Cardell S
    Eur J Immunol; 2004 Jan; 34(1):56-65. PubMed ID: 14971030
    [TBL] [Abstract][Full Text] [Related]  

  • 11. NKT cells act as regulatory cells rather than killer cells during activation of NK cell-mediated cytotoxicity by alpha-galactosylceramide in vivo.
    Chamoto K; Takeshima T; Kosaka A; Tsuji T; Matsuzaki J; Togashi Y; Ikeda H; Nishimura T
    Immunol Lett; 2004 Aug; 95(1):5-11. PubMed ID: 15325792
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Human NKT cells mediate antitumor cytotoxicity directly by recognizing target cell CD1d with bound ligand or indirectly by producing IL-2 to activate NK cells.
    Metelitsa LS; Naidenko OV; Kant A; Wu HW; Loza MJ; Perussia B; Kronenberg M; Seeger RC
    J Immunol; 2001 Sep; 167(6):3114-22. PubMed ID: 11544296
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Natural killer T cells and rheumatoid arthritis: friend or foe?
    Elewaut D
    Arthritis Res Ther; 2005; 7(2):88-9. PubMed ID: 15743495
    [No Abstract]   [Full Text] [Related]  

  • 14. Lysosomal glycosphingolipid recognition by NKT cells.
    Zhou D; Mattner J; Cantu C; Schrantz N; Yin N; Gao Y; Sagiv Y; Hudspeth K; Wu YP; Yamashita T; Teneberg S; Wang D; Proia RL; Levery SB; Savage PB; Teyton L; Bendelac A
    Science; 2004 Dec; 306(5702):1786-9. PubMed ID: 15539565
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Human NKT cells express granulysin and exhibit antimycobacterial activity.
    Gansert JL; Kiessler V; Engele M; Wittke F; Röllinghoff M; Krensky AM; Porcelli SA; Modlin RL; Stenger S
    J Immunol; 2003 Mar; 170(6):3154-61. PubMed ID: 12626573
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Signaling lymphocytic activation molecule-associated protein controls NKT cell functions.
    Chung B; Aoukaty A; Dutz J; Terhorst C; Tan R
    J Immunol; 2005 Mar; 174(6):3153-7. PubMed ID: 15749842
    [TBL] [Abstract][Full Text] [Related]  

  • 17. A novel function of Valpha14+CD4+NKT cells: stimulation of IL-12 production by antigen-presenting cells in the innate immune system.
    Tomura M; Yu WG; Ahn HJ; Yamashita M; Yang YF; Ono S; Hamaoka T; Kawano T; Taniguchi M; Koezuka Y; Fujiwara H
    J Immunol; 1999 Jul; 163(1):93-101. PubMed ID: 10384104
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Differential tumor surveillance by natural killer (NK) and NKT cells.
    Smyth MJ; Thia KY; Street SE; Cretney E; Trapani JA; Taniguchi M; Kawano T; Pelikan SB; Crowe NY; Godfrey DI
    J Exp Med; 2000 Feb; 191(4):661-8. PubMed ID: 10684858
    [TBL] [Abstract][Full Text] [Related]  

  • 19. CD1d-restricted NKT cells: an interstrain comparison.
    Hammond KJ; Pellicci DG; Poulton LD; Naidenko OV; Scalzo AA; Baxter AG; Godfrey DI
    J Immunol; 2001 Aug; 167(3):1164-73. PubMed ID: 11466330
    [TBL] [Abstract][Full Text] [Related]  

  • 20. NKT cells in tumor immunity: opposing subsets define a new immunoregulatory axis.
    Berzofsky JA; Terabe M
    J Immunol; 2008 Mar; 180(6):3627-35. PubMed ID: 18322166
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 28.